Mechanisms that drive inflammatory tumor microenvironment, tumor heterogeneity, and metastatic progression

Semin Cancer Biol. 2017 Dec:47:185-195. doi: 10.1016/j.semcancer.2017.08.001. Epub 2017 Aug 3.

Abstract

Treatment of cancer metastasis has been largely ineffective. It is paramount to understand the mechanisms underlying the metastatic process, of which the tumor microenvironment is an indispensable participant. What are the critical cellular and molecular players at the primary tumor site where metastatic cascade initiates? How is tumor-associated inflammation regulated? How do altered vasculatures contribute to metastasis? What is the dynamic nature or heterogeneity of primary tumors and what are the challenges to catch a moving target? This review summarizes recent progress, mechanistic understanding, and options for metastasis-targeted therapy.

Keywords: Heterogeneity; Inflammation/Immune; Microenvironment; Tumor metastasis; Tumor suppressor.

Publication types

  • Review

MeSH terms

  • Angiogenesis Inhibitors / pharmacology
  • Angiogenesis Inhibitors / therapeutic use
  • Animals
  • Biomarkers, Tumor
  • Clonal Evolution
  • Disease Progression
  • Humans
  • Inflammation / etiology
  • Inflammation / metabolism
  • Inflammation / pathology*
  • Molecular Targeted Therapy
  • Neoplasm Metastasis
  • Neoplasms / drug therapy
  • Neoplasms / etiology
  • Neoplasms / metabolism*
  • Neoplasms / pathology*
  • Neovascularization, Pathologic / drug therapy
  • Neovascularization, Pathologic / metabolism
  • Tumor Microenvironment* / drug effects
  • Tumor Microenvironment* / immunology

Substances

  • Angiogenesis Inhibitors
  • Biomarkers, Tumor